Related Experiment Video
Updated: May 27, 2026
10:29
Generation of Human Chimeric Antigen Receptor Regulatory T Cells
Published on: January 3, 2025
Targeting regulatory T cells in cancer
William L Byrne1, Kingston H G Mills, James A Lederer
1Cork Cancer Research Centre, Mercy University Hospital and Leslie C. Quick Jnr. Laboratory, University College Cork, Cork, Ireland.
Cancer Research
|November 10, 2011
Summary
Regulatory T cells promote tumor growth and metastasis by suppressing anti-tumor immunity. New strategies targeting these cells show promise for enhancing cancer immunotherapy efficacy and selectivity.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Regulatory T cells (Tregs) infiltrate tumors, providing growth and metastatic advantages.
- Tregs inhibit anti-tumor immunity and produce receptor activator of NF-κB (RANK) ligand, promoting cancer cell metastasis.
Purpose of the Study:
- To explore strategies for modulating regulatory T cells to enhance cancer immunotherapy.
- To address the challenges of specificity and potential autoimmune side effects associated with current Treg modulation methods.
Main Methods:
- Review of current strategies for Treg modulation, including depletion, functional interference, migration inhibition, and plasticity exploitation.
- Discussion of emerging technologies like RNA interference and tetramer-based targeting for improved Treg selectivity.
Main Results:
- Treg modulation can enhance cancer immunotherapy efficacy.
- Current strategies face challenges with specificity, potentially harming anti-tumor effector T cells or causing autoimmune diseases.
- Emerging technologies offer potential for more selective Treg targeting.
Conclusions:
- Targeting regulatory T cells is a viable strategy to improve cancer immunotherapy.
- Enhanced selectivity in Treg modulation is crucial to minimize side effects.
- Novel technologies hold promise for more effective and safer cancer treatments.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...